EVMN Competitors & Alternatives
Compare Evommune, Inc. with similar stocks in the same industry
Biotechnology
EVMN
Main Stock$7.24
-5.11%
Tradestie Score
29
Analyst Upside
+210.0%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Other
Major Customers
0
Diversified enterprise & commercial customer base.
Critical Suppliers
0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals
0
Sole-source / monopoly positioning in sub-sector.
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$3.63
-7.53%
|
$332.96M | - | 46 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.56
-1.51%
|
$328.62M | - | 26 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.54
-7.48%
|
$307.12M | - | 32 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$6.09
-1.85%
|
$304.12M | - | 47 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.52
-3.87%
|
$297.23M | - | 36 | Compare |
|
OMER
Omeros Corporation
|
$17.18
-1.80%
|
$281.75M | 14.9 | 55 | Compare |
|
DBVT
DBV Technologies S.A.
|
$10.26
-6.85%
|
$275.54M | - | 30 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.26
-0.82%
|
$269.08M | 0.1 | 58 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
+0.14%
|
$256.71M | - | 51 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.82
-0.08%
|
$240.89M | - | 44 | Compare |
More EVMN Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC None)
217 stocks in this industry